This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Lumiradx UK Ltd.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Victor Manneh: Innovator in Hemoglobin Assays
Introduction
Victor Manneh is a notable inventor based in Encinitas, CA (US). He has made significant contributions to the field of medical diagnostics, particularly in the development of innovative assays for hemoglobin A1c. With a total of 2 patents to his name, Manneh's work is paving the way for advancements in diabetes management.
Latest Patents
Manneh's latest patents focus on a method known as the saturation binding ratiometric assay. This method involves performing ratiometric assays for hemoglobin A1c, which is crucial for monitoring long-term glucose control in diabetic patients. The techniques described in his patents allow for a direct ratio determination between Hb A1c and normalized total hemoglobin. By utilizing a saturating amount of hemoglobin, the assay ensures that Hb A1c binds proportionately to a substrate. Additionally, the assay can incorporate a proximity label system for signal generation and/or labeled magnetic beads, and it can be configured as either homogeneous or heterogeneous assays.
Career Highlights
Victor Manneh is currently associated with LumiraDx UK Ltd., where he continues to innovate in the field of medical diagnostics. His work is characterized by a commitment to improving the accuracy and efficiency of hemoglobin assays, which are vital for effective diabetes management.
Collaborations
Manneh collaborates with various professionals in his field, including his coworker Sergei Svarovsky. Their combined expertise contributes to the advancement of diagnostic technologies.
Conclusion
Victor Manneh's contributions to the field of hemoglobin assays exemplify the impact of innovation in medical diagnostics. His patents and ongoing work at LumiraDx UK Ltd. highlight the importance of developing accurate and efficient methods for diabetes management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile